Royal Fund Management’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
Sell
-364
Closed -$24K 219
2020
Q1
$24K Buy
364
+19
+6% +$1.34K 0.01% 280
2019
Q4
$23K Buy
345
+33
+11% +$2.25K 0.01% 318
2019
Q3
$22K Hold
312
0.01% 310
2019
Q2
$22K Hold
312
0.01% 307
2019
Q1
$21K Hold
312
0.01% 294
2018
Q4
$18K Hold
312
0.01% 274
2018
Q3
$20K Sell
312
-24
-7% -$1.6K 0.01% 270
2018
Q2
$21K Buy
336
+24
+8% +$1.57K 0.01% 281
2018
Q1
$22K Hold
312
0.01% 269
2017
Q4
$23K Hold
312
0.01% 276
2017
Q3
$22K Sell
312
-52
-14% -$3.75K 0.01% 234
2017
Q2
$26K Buy
364
+52
+17% +$3.86K 0.01% 200
2017
Q1
$22K Hold
312
0.01% 209
2016
Q4
$20K Buy
+312
New +$21.4K 0.01% 198

Other funds holding CL

Royal Fund Management's CL Position: Q2 2020 in Review

Royal Fund Management sold out of Colgate-Palmolive (CL) in Q2 2020, closing a stake of 364 shares — an estimated $24K sold.

Royal Fund Management first reported a position in CL in Q4 2016 and held it in 14 quarters. The position peaked at $26K in Q2 2017. 1,518 funds tracked by Wall St. Rank hold CL as of Q2 2020.

  • Royal Fund Management reported no remaining Colgate-Palmolive position as of Q2 2020 after selling out during the quarter.
  • Royal Fund Management sold 364 Colgate-Palmolive shares in Q2 2020, an estimated $24K.
  • Royal Fund Management first reported a position in Colgate-Palmolive in Q4 2016 and held it in 14 quarters.
  • Royal Fund Management's Colgate-Palmolive position peaked at $26K in Q2 2017.
  • 1,518 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q2 2020.

Based on Royal Fund Management's 13F filing for Q2 2020, filed 6 Aug 2020.